Last edition
News about " EIR from U.S. FDA"
Lupin's Goa manufacturing plant receives EIR from US FDA
Global pharma major Lupin Limited announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (FDA) for its Goa manufacturing facility, after the inspection of the facility in September 2021
EIR From US FDA | 14/12/2021 | By Darshana | 273
Lupin's Pithampur Unit-1 facility receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between February 3, 2020 and February 11, 2020
EIR From U.S. FDA | 30/04/2020 | By Darshana | 429
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy